Cure My Disease

Don't miss your cure!

 Log in / Sign up

Pain relief combo beats standard numbing drug

NCT ID NCT07469826

Symptom relief Sponsor: Jinnah Postgraduate Medical Centre Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two numbing medicines for pain after minor surgery. 100 adults received either bupivacaine alone or bupivacaine mixed with tramadol. The combination led to less pain, especially 24 hours later, suggesting a simple way to improve recovery and comfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

100 people

The number who actually took part.

Started

Oct 2022

Finished

May 2023

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * All patients undergoing elective procedure under local anesthesia * Either gender. * Age 18-60 years. Exclusion Criteria: * Procedures Under general anesthesia. * Diabetic patients, assessed by history and clinically and HbA1c \>6.5% * Patients with metastatic disease, assessed by history, clinically and by imaging. * Patients who are I/V opioid abusers will be excluded.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Post operative pain, acute are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Post operative pain, acute

Contacts and locations

Locations

  • Jinnah postgraduate medical university

    Karachi, Sindh, 75510, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.